| Preview | Issue Date | Title / Name | Author(s) |
| Sep-2023 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma | Sim, H. W.; Wachsmuth, L.; Barnes, E. H.; Yip, S.; Koh, E. S.; Hall, M.; Jennens, R.; Ashley, D. M.; Verhaak, R. G.; Heimberger, A. B.; Rosenthal, M. A.; Hovey, E. J.; Ellingson, B. M.; Tognela, A.; Gan, H. K.; Wheeler, H.; Back, M.; McDonald, K. L.; Long, A.; Cuff, K.; Begbie, S.; Gedye, C.; Mislang, A.; Le, Hien; Johnson, M. O.; Kong, B. Y.; Simes, J. R.; Lwin, Z.; Khasraw, M.; Begbie, Stephen | |
| Dec-2024 | Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting - Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial | Grimison, P.; Mersiades, A.; Kirby, A.; Morton, R.L.; Walsh, A.; Lee, Y.; Simes, R.J.; Stockler, M.R.; Tognela, A.; Olver, I.; Haber, P.; Abdi, E.; Della-Fiorentina, S.; Aghmesheh, M.; Fox, P.; Briscoe, Karen; Sanmugarajah, J.; Marx, G.; Kichenadasse, G.; Wheeler, H.; Chan, M.; Shannon, J.; Gedye, C.; Begbie, Stephen; Briscoe, Karen; Begbie, Stephen | |
| Aug-2024 | Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. | Grimison, P.; Mersiades, A.; Kirby, A.; Tognela, A.; Olver, I.; Morton, R. L.; Haber, P.; Walsh, A.; Lee, Y.; Abdi, E.; Della-Fiorentina, S.; Aghmesheh, M.; Fox, P.; Briscoe, K.; Sanmugarajah, J.; Marx, G.; Kichenadasse, G.; Wheeler, H.; Chan, M.; Shannon, J.; Gedye, C.; Begbie, S.; et al.; Begbie, Stephen; Briscoe, Karen | |
| Nov-2020 | Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. | Grimison, P.; Mersiades, A.; Kirby, A.; Lintzeris, N.; Morton, R.; Haber, P.; Olver, I.; Walsh, A.; McGregor, I.; Cheung, Y.; Tognela, A.; Hahn, C.; Briscoe, Karen; Aghmesheh, M.; Fox, P.; Abdi, E.; Clarke, S.; Della-Fiorentina, S.; Shannon, J.; Gedye, C.; Begbie, Stephen; Simes, J.; Stockler, M.; Briscoe, Karen; Begbie, Stephen | |
| Feb-2024 | A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma | Conduit, C.; Davis, I. D.; Goh, J. C.; Kichenadasse, G.; Gurney, H.; Harris, C. A.; Pook, D.; Krieger, L.; Parnis, F.; Underhill, C.; Adams, D.; Roncolato, F.; Joshua, A.; Ferguson, T.; Prithviraj, P.; Morris, M.; Harrison, M.; Begbie, S.; Hovey, E.; George, M.; Liow, E. C.; Link, E. K.; McJannett, M.; Gedye, C.; Australian and New Zealans Urogental and Prostrate Cancer Trils Group (ANZUP); UNISoN Investigators; Begbie, Stephen | |
